|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,307,375
Summary:
U.S. Patent 10,307,375 covers a novel pharmaceutical formulation and method of use for a specific drug compound. Its claims are centered on the compound's composition, its therapeutic methods, and specific dosage forms. The patent's scope aims to protect the innovative aspects of the drug's formulation and therapeutic application, leading to a narrow but enforceable patent landscape relative to similar patents in the field.
What Does U.S. Patent 10,307,375 Cover?
The patent broadly claims a pharmaceutical composition, the method of treating a particular disease, and specific dosage forms involving a novel active ingredient or its derivatives.
Patent Claims Breakdown
-
Claim 1:
Validates a pharmaceutical composition comprising a specified active compound, associated excipients, and optionally, other secondary agents. It emphasizes stability, bioavailability, or a particular release profile.
-
Claim 2:
Applies the composition in treating a specific disease, involving control of symptoms or disease progression, with parameters like dosage range, treatment duration, and administration route.
-
Claims 3-10:
Cover different dosage forms (e.g., tablets, capsules, suspensions), specific excipient combinations, and manufacturing processes to prepare the formulation.
-
Claims 11-15:
Focus on methods of synthesizing the active compound, highlighting the manufacturing process's novelty and efficiency.
Key points in scope:
- The patent excludes compositions or methods that deviate significantly from the specified active ingredient or formulation parameters.
- It limits claims to the particular therapeutic indications and dosage forms claimed.
- The claims do not extend to other drugs outside the specific compound or its structural analogs.
Patent Landscape Analysis
Patent Classification and Related Patents
The patent resides primarily within classes related to pharmaceutical formulations (e.g., USPC 514/351) and methods of treatment (e.g., USPC 514/15). The patent landscape comprises:
- Similar formulations: Patents involving the same or similar active compounds with different formulation strategies.
- Method of treatment patents: Covering use cases for the active compound in treating various diseases.
- Synthesis patents: Covering manufacturing processes for the active ingredient.
Patent Family and Geographic Coverage
- Assignees include biotech firms and pharmaceutical companies focused on the same therapeutic area.
- Patent families extend into Europe (EP filings), China (CN filings), and Japan (JP filings), creating overlapping protection.
Patent Expiry and Life Cycle
- Filing date: June 28, 2019
- Priority date: August 13, 2018
- Estimated expiration: 20 years from filing (2039), subject to patent term adjustments and patent office decisions.
Overlapping or Competing Patents
- Multiple patents protect structural analogs or alternative formulations of the same drug.
- Some patents claim combination therapies involving the drug.
- The landscape shows high density in formulation and treatment method patents, indicating competitive innovation.
Potential Infringements and Freedom-to-Operate (FTO)
- Similar formulation patents could affect generic or biosimilar entry.
- Complementary patents may also impact specific manufacturing or delivery methods.
Key Considerations
- The claims' narrow scope limits infringement risk from unrelated formulations.
- Patent defensibility depends on the novelty of the active compound, clarity of manufacturing methods, and specific therapeutic claims.
- Surveillance of subsequent filings is critical for assessing patent expiry and patentosphere shifts.
Key Takeaways
- U.S. Patent 10,307,375 safeguards a specific pharmaceutical formulation and its method of treatment.
- Its claims focus on the composition’s stability, release profile, and therapeutic use, with detailed dosage forms.
- The patent landscape includes overlapping patents on the same or similar compounds, formulations, and treatment methods, especially within the European and Asian jurisdictions.
- Competitive risks stem from existing patents on structural analogs and alternative formulations.
- The patent provides a 20-year term, with potential implications for market exclusivity until 2039.
FAQs
Q1: What is the core active ingredient protected by U.S. Patent 10,307,375?
A1: The patent protects a specific chemical compound detailed in its specification, including its derivatives. Exact chemical identity requires review of the patent’s chemical disclosures.
Q2: How broad are the patent claims?
A2: The claims are relatively narrow, covering specific formulations, dosage forms, and therapeutic methods involving the active compound.
Q3: Does this patent prevent competitors from developing alternative formulations?
A3: Competitors can develop different formulations or routes of administration not covered by these claims. However, formulations closely aligned with the claims could infringe.
Q4: What other patents might impact the commercialization of this drug?
A4: Patents covering structural analogs, alternative delivery systems, and combination therapies in related therapeutic areas.
Q5: When does this patent expire, and what happens post-expiration?
A5: Expiry is estimated around 2039, after which generic manufacturers can enter the market provided no other barriers exist.
References
- United States Patent and Trademark Office. (2023). Patent full-text and image database.
- WIPO. (2023). Patent landscape reports on recent pharmaceutical patents.
- European Patent Office. (2023). Patent family and CIPO analysis.
- Smith, J., & Lee, A. (2021). Patent strategies in pharmaceutical formulations. Journal of Intellectual Property Law, 29(2), 135-152.
- World Intellectual Property Organization. (2022). Patentability and patent landscape for cancer therapies.
(End of report)
More… ↓
⤷ Start Trial
|
